Skip to content

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

AdminNov 14, 2023< 1 min read

COTA and Aetion partner to expand access to real-world data for oncology research

At the heart of every oncology breakthrough is trustworthy data. Researchers rely on access to complete, accurate, timely, longitudinal information about cancer patients to observe the impacts of new therapies in clinical trials and make decisions about what to recommend for individuals with cancer in the community.

Read More

RELATED ARTICLES